UniSuper Management’s Charles River Laboratories CRL Stock Holding History

UniSuper Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$987K	Hold	3,344	–	–	﹤0.01%	513
2026 Q2	$758K	Sell	3,344 -5,581	-63%	-$994K	﹤0.01%	536
2026 Q1	$1.54M	Buy	8,925 +293	+3%	+$54.3K	0.01%	511
2025 Q4	$1.72M	Sell	8,632 -2,937	-25%	-$533K	0.01%	495
2025 Q3	$1.81M	Buy	11,569 +595	+5%	+$94.5K	0.01%	523
2025 Q2	$1.67M	Buy	10,974 +1,467	+15%	+$196K	0.01%	523
2025 Q1	$1.43M	Sell	9,507 -526	-5%	-$88.2K	0.01%	534
2024 Q4	$1.85M	Buy	10,033 +1,724	+21%	+$332K	0.01%	477
2024 Q3	$1.64M	Buy	8,309 +1,203	+17%	+$250K	0.01%	506
2024 Q2	$1.47M	Buy	7,106 +3,103	+78%	+$703K	0.01%	500
2024 Q1	$1.08M	Buy	4,003 +3,278	+452%	+$783K	0.01%	492
2023 Q4	$171K	Sell	725 -73	-9%	-$14.4K	﹤0.01%	557
2023 Q3	$156K	Sell	798 -116	-13%	-$23.8K	﹤0.01%	509
2023 Q2	$192K	Buy	+914	New	+$182K	﹤0.01%	480

Other funds holding CRL

Cooke & Bieler Philadelphia, Pennsylvania $6.36B AUM 0.55% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Locust Wood Capital Advisers New York $4.43B AUM 19.95% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

J.P. Marvel Investment Advisors Boston, Massachusetts $863M AUM 50.23% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

UniSuper Management's CRL Position: Q3 2026 in Review

UniSuper Management held its Charles River Laboratories (CRL) position steady in Q3 2026 at 3,344 shares worth $987K. The position accounts for ﹤0.01% of the portfolio, ranked #513.

UniSuper Management first reported a position in CRL in Q2 2023 and has held it in 14 quarters since. The position peaked at $1.85M in Q4 2024. 211 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

UniSuper Management held 3,344 shares of Charles River Laboratories worth $987K as of Q3 2026.
UniSuper Management left its Charles River Laboratories share count unchanged in Q3 2026.
Charles River Laboratories made up ﹤0.01% of UniSuper Management's portfolio in Q3 2026, its #513 holding.
UniSuper Management first reported a position in Charles River Laboratories in Q2 2023 and has held it in 14 quarters since.
UniSuper Management's Charles River Laboratories position peaked at $1.85M in Q4 2024.
211 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on UniSuper Management's 13F filing for Q3 2026, filed 26 Oct 2026.